Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: Phase II study

Cancer Chemotherapy and Pharmacology

Volumn 63, Issue 1, 2008, Pages 9-17

  Chang, Peter Mu Hsin ^a,b   Chen, Po Min ^a,b   Chu, Pen Yuan ^a,b   Wang, Ling Wei ^a,b   Tai, Shyh Kuan ^a,b   Tsai, Tung Lung ^a,b   Huang, Jui Lin ^a,b   Wang, Yi Fen ^a,b   Chang, Shyue Yih ^a,b   Yang, Muh Hwa ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Head and neck cancer; Induction chemotherapy; Organ preservation; Pharmacokinetic modulating chemotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID; UFT; UFUR; UNCLASSIFIED DRUG;

ADULT; AGED; ANEMIA; ANOREXIA; ARTICLE; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; DIARRHEA; DISEASE FREE SURVIVAL; DRUG EFFICACY; DYSPHAGIA; ESOPHAGITIS; FEMALE; HEAD AND NECK CANCER; HEMATOLOGIC DISEASE; HUMAN; INFECTION; KIDNEY DISEASE; LIVER TOXICITY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUROPATHY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SIDE EFFECT; THROMBOCYTOPENIA; VOMITING; WEIGHT REDUCTION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; GASTROINTESTINAL DISEASES; HEAD AND NECK NEOPLASMS; HEMATOLOGIC DISEASES; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION; SALVAGE THERAPY; SURVIVAL ANALYSIS; TEGAFUR; TREATMENT OUTCOME; URACIL;

EID: 53149136566     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-008-0702-1     Document Type: Article

References (43)

1. D Hardisson 2003 Molecular pathogenesis of head and neck squamous cell carcinoma Eur Arch Otorhinolaryngol 260 502 508
2. Department of Health, the Executive Yuan (2004) Cancer registry annual report in Taiwan area. Department of Health, Executive Yuan, ROC
3. PS Ho YC Ko YH Yang TY Shieh CC Tsai 2002 The incidence of oropharyngeal cancer in Taiwan: an endemic betel quid chewing area J Oral Pathol Med 31 213 239
4. TY Seiwert EEW Cohen 2005 State-of-the-art management of locally advanced head and neck cancer Br J Cancer 292 1341 1348
5. MR Posner DM Hershock CR Blajman E Mickiewicz E Winquist V Gorbounova S Tjulandin DM Shin K Cullen TJ Ervin BA Murphy LE Raez RB Cohen M Spaulding RB Tishler B Roth C Viroglio Rdel V Venkatesan I Romanov S Agarwala KW Harter M Dugan A Cmelak AM Markoe PW Read L Steinbrenner AD Colevas CM Norris Jr RI Haddad 2007 Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer N Engl J Med 357 1705 1715
6. DJ Adelstein Y Li GL Adams H Wagner Jr JA Kish JF Ensley DE Schuller AA Forastiere 2003 An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer J Clin Oncol 21 92 98
7. F Denis P Garaud E Bardet M Alfonsi C Sire T Germain P Bergerot B Rhein J Tortochaux G Calais 2004 Final results of the 94-01 French head and neck oncology and radiotherapy group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma J Clin Oncol 22 69 76
8. AA Forastiere H Goepfert M Maor TF Pajak R Weber W Morrison B Glisson A Trotti JA Ridge C Chao G Peters DJ Lee A Leaf J Ensley J Cooper 2003 Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N Engl J Med 349 2091 2098
9. A Paccagnella A Orlando C Marchiori PL Zorat G Cavaniglia VC Sileni Jirillo AL Tomio G Fila A Fede L Endrizzi M Bari E Sampognaro M Balli A Gava GL Pappagallo MV Fiorention 1994 Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Grupo di Studio sui Tumori della testa e del collo. J Natl Cancer Inst 86 265 272
10. PL Zorat A Paccagnella G Cavaniglia L Loreggian A Gava CA Mione F Boldrin C Marchiori F Lunghi A Fede A Bordin MC Da Mosto VC Sileni A Orlando A Jirillo L Tomio GL Pappagallo MG Ghi 2004 Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow up J Natl Cancer Inst 96 1714 1717
11. JB Vermorken E Remenar C Van Herpen T Gorlia R Mesia M Degardin JS Stewart S Jelic J Betka JH Preiss D van den Weyngaert A Awada D Cupissol HR Kienzer A Rey I Desaunois J Bernier JL Lefebvre 2007 Cisplatin, fluourouracil, and docetaxel in unresectable head and neck N Engl J Med 357 1695 1704
12. R Hitt A Lopez Pousa J Martinez-Trufero V Escrig J Carles A Rizo D Isla M ME Vega JL Martí F Lobo P Pastor V Valentí J Belón MA Sánchez C Chaib C Pallarés A Antón A Cervantes L Paz-Ares H Cortés-Funes 2005 Phase III study comparing cisplatin plus fluourouacil to paclitaxel, cisplatin, and fluourouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol 23 8636 8644
13. R Hitt 2006 Induction chemotherapy in head and neck cancer. Ann Oncol Suppl 10 x42 x44
14. S Fujii M Fukushima Y Shimamoto T Shirasaka 1989 Pharmacokinetic modulation of plasma 5-fluorouracil concentration to potentiate the antitumor activity of continuous venous infusion of 5-Fluorouracil Jpn J Cancer Res 80 509 512
15. RA Fleming G Milano A Thyss MC Etienne N Renée M Schneider F Demani 1992 Correlation between dihydropyrimidine dehydrogenase activity in peripheral mononuclear cells and systemic clearance of fluorouracil in cancer patients Cancer Res 52 2899 2902
16. T Takechi J Uchida A Fujioka M Fukushima 1997 Enhancing 5-fluorouracil cytotoxicity by inhibiting dihydropyrimidine dehydrogenase activity with uracil in human tumor cells Int J Oncol 11 1041 1044
17. R Yoshikawa M Kusunoki H Yanagi M Noda JI Furuyama T Yamamura T Hashimoto-Tamaoki 2001 Dual antitumor effects of 5-Fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy Cancer Res 61 1029 1037
18. M Kusunoki H Yanagi M Noda T Yamamura 1999 The usefulness of pharmacokinetic modulating chemotherapy (UFT plus 5FU) in the treatment of unresectable colorectal carcinomas. Oncol Rep 6 547 552
19. Calais G, Pointreau Y, Alfonsi M, Sire C, Tuchais C, Tortochaux J, Bourhis J, Guerrif S, Garaud P (2006) Randomized phase III trial comparing induction chemotherapy using cisplatin (P) fluorouracil (F) with or without docetaxel (T) for organ preservation in hypopharynx and larynx cancer. Preliminary results of GORTEC 2000-01. Proc Am Soc Clin Oncol 18s: abstr 5506
20. MK Gibson Y Li B Murphy MH Hussain RC DeConti J Ensley AA Forastiere 2005 Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an Intergroup Trial of the Eastern Cooperative Oncology Group J Clin Oncol 23 3562 3567
21. R Simon 1989 Optimal two stage design for phase II clinical trials Control Clin Trials 10 1 10
22. SG Urba J Moon PG Shankar Giri DJ Adelstein E Hanna GH Yoo M LeBlanc JF Ensley DE Schuller 2005 Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial J Clin Oncol 23 88 95
23. P Therasse SG Arbuck EA Eisenhauer J Wanders RS Kaplan L Rubinstein J Verweij M Van Glabbeke AT van Oosterom MC Christian SG Gwyther 2000 New guidelines to evaluate the response to treatment in solid tumors J Natl Cancer Inst 92 205 216
24. National Cancer Institute (1999) Cancer Therapy Evaluation Program: Common Toxicity Criteria. Version 2.0; http://www.ctep.info.nih.gov (20 April 1999, date last accessed)
25. E Giovannetti HHJ Backus D Wouters CG Ferreira VM van Houten RH Brakenhoff MF Poupon A Azzarello HM Pinedo GJ Peters 2007 Changes in the status of p53 affect drug sensitivity to thymidylate synthase (TS) inhibitors by altering TS levels Br J Cancer 96 769 775
26. F Bunz PM Hwang C Torrance T Waldman Y Zhang L Dillehay J Williams C Lengauer KW Kinzler B Vogelstein 1999 Disruption of p53 in human cancer cells alters the responses to therapeutic agents J Clin Invest 104 263 269
27. M Kusunoki H Yanagi H Kotera M Noda T Yamamura 1998 Effects of pharmacokinetic modulating chemotherapy using oral UFT and continuous venous 5-FU infusion on the prognosis of irradiated rectal carcinomas with p53 overexpression Int J Oncol 13 653 657
28. F Perrone L Mariani E Pastore M Orsenigo S Suardi B Marcomini L DaRiva L Licitra A Carbone MA Pierotti S Pilotti 2007 p53 codon 72 polymorphisms in human papillomavirus-negative and human papillomavirus-positive squamous cell carcinomas of the oropharynx Cancer 109 2461 2465
29. R Cabanillas JP Rodrigo A Astudillo F Dominguez C Suarez MD Chiara 2007 P53 expression in squamous cell carcinomas of the supraglottic larynx and its lymph node metastases: new results for an old question Cancer 109 1791 1798
30. Rivera F, Vega-Villegas ME, López-Brea M, Isla D, Mayorga M, Galdós P, Rubio A, Del Valle A, García-Reija F, García-Montesinos B, Rodríguez-Iglesias J, Mayordomo J, Rama J, Saiz-Bustillo R, Sanz-Ortiz J (2007) Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC) Cancer Chemother Pharmacol Sep 28 Epub ahead of print
31. HM Wang CS Wang JS Chen IH Chen CT Liao TC Chang 2002 Cisplatin, tegafur, and leucovorin: a moderately effective and minimally toxic outpatient neoadjuvant chemotherapy for locally advanced squamous cell carcinoma of the head and neck Cancer 94 2989 2995
32. JL Lefebvre D Chevalier B Luboinski A Kirkpatrick L Collette T Sahmoud 1996 Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial J Natl Cancer Inst 88 890 899
33. Department of Veterans Affairs Laryngeal Cancer Study Group 1991 Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer N Engl J Med 324 1685 1690
34. JF Ensley JR Jacobs A Weaver J Kinzie J Crissman JA Kish G Cummings M Al-Sarraf 1984 Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancer of the head and neck Cancer 54 811 814
35. J Ensley J Kish E Tapazoglou J Jacobs A Weaver D Atkinson K Ahmed R Mathog M Al-Sarraf 1988 An intensive, five course, alternating combination chemotherapy induction regimen used in patients with advanced unresectable head and neck cancer J Clin Oncol 6 1147 1153
36. EE Vokes RR Weichselbaum R Mick JM McEvilly DJ Haraf WR Panje 1992 Favourable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer J Natl Cancer Inst 84 877 882
37. E Avraham 2007 Commentary: induction chemotherapy for head and neck cancer: Hypothesis-based rather than evidence-based medicine Oncol 12 975 977
38. SK Sarkar NB Patra J Goswami S Basu 2007 Comparative study of efficacy and toxicities of cisplatin vs. vinorelbine as radiosensitisers in locally advanced head and neck cancer J Laryngol Otol 20 1 5
39. S Kumar K Dimri R Khurana N Rastogi KJ Das P Lal 2007 A randomised trial of radiotherapy compared with cisplatin chemo-radiotherapy in patients with unresectable squamous cell cancer of the esophagus Radiother Oncol 83 139 147
40. O Altundag I Gullu K Altundag S Yalcin E Ozyar M Cengiz F Akyol T Yucel S Hosal B Sozeri 2005 Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients Head Neck 27 15 21
41. SN Geeta TK Padmanabhan J Samuel K Pavithran S Iyer MA Kuriakose 2006 Comparison of acute toxicities of two chemotherapy schedules for head and neck cancers J Cancer Res Ther 2 100 104
42. H Katori M Tsukuda T Taguchi 2007 Concurrent chemoradiotherapy with carboplatin and uracil-f tegafur (UFT) for patients with poor performance status with locally advanced squamous cell carcinoma of the head and neck (SCCHN) Acta Otolaryngol 8 1 6
43. JH Park SY Nam SW Lee SB Kim SY Kim BJ Lee KJ Cho JH Kim SD Ahn SS Shin SH Choi JH Ahn EK Choi 2005 Radiation therapy with UFT and low dose weekly cisplatin for nasopharyngeal carcinoma Auris Nasus Larynx 32 43 48